• 1
    Sibley GS. Radiotherapy for patients with medically inoperable Stage I nonsmall cell lung carcinoma: smaller volumes and higher doses-a review. Cancer. 1998; 82: 433-438.
  • 2
    Heinzerling JH, Kavanagh B, Timmerman RD. Stereotactic ablative radiation therapy for primary lung tumors. Cancer J. 2011; 17: 28-32.
  • 3
    Vansteenkiste JF, Stroobants SS. PET scan in lung cancer: current recommendations and innovation. J Thorac Oncol. 2006; 1: 71-73.
  • 4
    Yasufuku K, Chiyo M, Koh E, et al. Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer. Lung Cancer. 2005; 50: 347-354.
  • 5
    Gildea TR, Mazzone PJ, Karnak D, Meziane M, Mehta AC. Electromagnetic navigation diagnostic bronchoscopy: a prospective study. Am J Respir Crit Care Med. 2006; 174: 982-989.
  • 6
    Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Handbook: TNM Classification of Malignant Tumors. 6th ed. New York, NY: Springer-Verlag; 2002.
  • 7
    Ludwig MS, Goodman M, Miller DL, Johnstone PA. Postoperative survival and the number of lymph nodes sampled during resection of node-negative nonsmall cell lung cancer. Chest. 2005; 128: 1545-1550.
  • 8
    Mery CM, Pappas AN, Bueno R, et al. Similar long-term survival of elderly patients with nonsmall cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest. 2005; 128: 237-245.
  • 9
    Ravdin PM, Davis G. Prognosis of patients with resected nonsmall cell lung cancer: impact of clinical and pathologic variables. Lung Cancer. 2006; 52: 207-212.
  • 10
    Rineer J, Schreiber D, Katsoulakis E, et al. Survival following sublobar resection for early-stage nonsmall cell lung cancer with or without adjuvant external beam radiation therapy: a population-based study. Chest. 2010; 137: 362-368.
  • 11
    Varlotto JM, Recht A, Nikolov M, Flickinger JC, Decamp MM. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer. Cancer. 2009; 115: 851-858.
  • 12
    Whitson BA, Groth SS, Andrade RS, Maddaus MA, Habermann EB, D'Cunha J. Survival after lobectomy versus segmentectomy for stage I nonsmall cell lung cancer: a population-based analysis. Ann Thorac Surg. 2011; 92: 1943-1950.
  • 13
    Wisnivesky JP, Bonomi M, Henschke C, Iannuzzi M, McGinn T. Radiation therapy for the treatment of unresected stage I-II nonsmall cell lung cancer. Chest. 2005; 128: 1461-1467.
  • 14
    Wisnivesky JP, Halm E, Bonomi M, Powell C, Bagiella E. Effectiveness of radiation therapy for elderly patients with unresected stage I and II nonsmall cell lung cancer. Am J Respir Crit Care Med. 2010; 181: 264-269.
  • 15
    Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.
  • 16
    Rami-Porta R, Ball D, Crowley J, et al; International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol. 2007; 2: 593-602.
  • 17
    Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011; 61: 212-236.
  • 18
    Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman BJ, Senan S. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I nonsmall-cell lung cancer: a population-based time-trend analysis. J Clin Oncol. 2010; 28: 5153-5159.
  • 19
    Pan H, Simpson DR, Mell LK, Mundt AJ, Lawson JD. A survey of stereotactic body radiotherapy use in the United States. Cancer. 2011; 117: 4566-4572.
  • 20
    Liao ZX, Komaki RR, Thames HDJr, et al. Influence of technologic advances on outcomes in patients with unresectable, locally advanced nonsmall-cell lung cancer receiving concomitant chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2010; 76: 775-781.
  • 21
    National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365: 395-409.
  • 22
    Janssen-Heijnen ML, Coebergh JW, Klinkhamer PJ, Schipper RM, Splinter TA, Mooi WJ. Is there a common etiology for the rising incidence of and decreasing survival with adenocarcinoma of the lung? Epidemiology. 2001; 12: 256-258.
  • 23
    Bradley JD, El Naqa I, Drzymala RE, Trovo M, Jones G, Denning MD. Stereotactic body radiation therapy for early-stage nonsmall-cell lung cancer: the pattern of failure is distant. Int J Radiat Oncol Biol Phys. 2010; 77: 1146-1150.
  • 24
    Nath SK, Sandhu AP, Kim D, et al. Locoregional and distant failure following image-guided stereotactic body radiation for early-stage primary lung cancer. Radiother Oncol. 2011; 99: 12-17.
  • 25
    Paravati AJ, Johnstone D, Aitken C. Patterns of failure and predictive value of PET-CT after stereotactic radiotherapy for stage I lung cancer. Int J Radiat Oncol Biol Phys. 2009; 75: S453.